C4 Therapeutics, Inc. (CCCC) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.27 | +16.4% |
| 2024 | $-1.52 | +43.1% |
| 2023 | $-2.67 | -1.9% |
| 2022 | $-2.62 | -44.0% |
| 2021 | $-1.82 | +68.8% |
| 2020 | $-5.83 | +81.2% |
| 2019 | $-31.03 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.27 | +16.4% |
| 2024 | $-1.52 | +43.1% |
| 2023 | $-2.67 | -1.9% |
| 2022 | $-2.62 | -44.0% |
| 2021 | $-1.82 | +68.8% |
| 2020 | $-5.83 | +81.2% |
| 2019 | $-31.03 | — |